Theriva Biologics, Inc. Foreign Currency Transaction Gain (Loss), before Tax
Theriva Biologics, Inc. (TOVX) reported Foreign Currency Transaction Gain (Loss), before Tax of -$1.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Other Income
us-gaap:ForeignCurrencyTransactionGainLossBeforeTax · last filed 2026-08-11
- Theriva Biologics, Inc. foreign currency transaction gain (loss), before tax for the quarter ending 2026-06-30 was -$1.00K, a 105.00% decline year-over-year.
- Theriva Biologics, Inc. foreign currency transaction gain (loss), before tax for the quarter ending 2026-03-31 was $1.00K.
- Theriva Biologics, Inc. foreign currency transaction gain (loss), before tax for the quarter ending 2025-12-31 was -$5.00K.
- Theriva Biologics, Inc. foreign currency transaction gain (loss), before tax for the quarter ending 2025-09-30 was $14.00K, a 366.67% increase year-over-year.
- Theriva Biologics, Inc. foreign currency transaction gain (loss), before tax for fiscal 2025 was $25.00K.
- Theriva Biologics, Inc. foreign currency transaction gain (loss), before tax for fiscal 2024 was -$4.00K, a 233.33% decline from fiscal 2023.
- Theriva Biologics, Inc. foreign currency transaction gain (loss), before tax for fiscal 2023 was $3.00K.
- Theriva Biologics, Inc. foreign currency transaction gain (loss), before tax for fiscal 2022 was -$41.00K.
| Period end | Foreign Currency Transaction Gain (Loss), before Tax 3 month | Foreign Currency Transaction Gain (Loss), before Tax 6 month | Foreign Currency Transaction Gain (Loss), before Tax 9 month | Foreign Currency Transaction Gain (Loss), before Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$1.00K 10-Q · filed 2026-08-11 | $0.00 derived: sum of 2 quarters · filed 2026-08-11 | -$5.00K derived: sum of 3 quarters · filed 2026-08-11 | $9.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | $1.00K 10-Q · filed 2026-05-05 | -$4.00K derived: sum of 2 quarters · filed 2026-05-05 | $10.00K derived: sum of 3 quarters · filed 2026-05-05 | $30.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | -$5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $9.00K derived: sum of 2 quarters · filed 2026-03-12 | $29.00K derived: sum of 3 quarters · filed 2026-08-11 | $25.00K 10-K · filed 2026-03-12 |
| 2025-09-30 | $14.00K 10-Q · filed 2025-11-12 | $34.00K derived: sum of 2 quarters · filed 2026-08-11 | $30.00K 10-Q · filed 2025-11-12 | $26.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | $20.00K 10-Q · filed 2026-08-11 | $17.00K 10-Q · filed 2026-08-11 | $12.00K derived: sum of 3 quarters · filed 2026-08-11 | $15.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | -$3.00K 10-Q · filed 2026-05-05 | -$8.00K derived: sum of 2 quarters · filed 2026-05-05 | -$5.00K derived: sum of 3 quarters · filed 2026-05-05 | -$6.00K derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | -$5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$2.00K derived: sum of 2 quarters · filed 2026-03-12 | -$3.00K derived: sum of 3 quarters · filed 2026-03-12 | -$4.00K 10-K · filed 2026-03-12 |
| 2024-09-30 | $3.00K 10-Q · filed 2025-11-12 | $2.00K derived: sum of 2 quarters · filed 2025-11-12 | $1.00K 10-Q · filed 2025-11-12 | -$3.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | -$1.00K 10-Q · filed 2025-08-11 | -$2.00K 10-Q · filed 2025-08-11 | -$6.00K derived: sum of 3 quarters · filed 2025-08-11 | $0.00 derived: sum of 4 quarters · filed 2025-08-11 |
| 2024-03-31 | -$1.00K 10-Q · filed 2025-05-14 | -$5.00K derived: sum of 2 quarters · filed 2025-05-14 | $1.00K derived: sum of 3 quarters · filed 2025-05-14 | -$3.00K derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | -$4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $2.00K derived: sum of 2 quarters · filed 2025-03-06 | -$2.00K derived: sum of 3 quarters · filed 2025-03-06 | $3.00K 10-K · filed 2025-03-06 |
| 2023-09-30 | $6.00K 10-Q · filed 2024-11-12 | $2.00K derived: sum of 2 quarters · filed 2024-11-12 | $7.00K 10-Q · filed 2024-11-12 | $7.00K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | -$4.00K 10-Q · filed 2024-08-13 | $1.00K 10-Q · filed 2024-08-13 | $1.00K derived: sum of 3 quarters · filed 2024-08-13 | -$8.00K derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $6.00K 10-Q · filed 2024-05-07 | $5.00K derived: sum of 2 quarters · filed 2024-05-07 | -$4.00K derived: sum of 3 quarters · filed 2024-05-07 | -$13.00K derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | -$10.00K derived: sum of 2 quarters · filed 2024-03-25 | -$19.00K derived: sum of 3 quarters · filed 2024-03-25 | -$41.00K 10-K · filed 2024-03-25 |
| 2022-09-30 | -$9.00K 10-Q · filed 2023-11-13 | -$18.00K derived: sum of 2 quarters · filed 2023-11-13 | -$40.00K 10-Q · filed 2023-11-13 | |
| 2022-06-30 | -$9.00K 10-Q · filed 2023-08-08 | -$31.00K 10-Q · filed 2023-08-08 | ||
| 2022-03-31 | -$23.00K 10-Q · filed 2023-05-11 | |||
| 2021-12-31 | $0.00 10-K · filed 2023-03-30 | |||
| 2021-06-30 | $0.00 10-Q · filed 2022-08-11 | $0.00 derived: sum of 2 quarters · filed 2022-08-11 | ||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |